156 - Leveraging the Host Response for Infectious Disease Diagnosis and Pathogen Discovery

Friday, October 18, 2024

1:45 PM – 3:00 PM US PT

Location: 502 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Nira Pollock, MD, PhD (she/her/hers)

Co-Director, Infectious Diseases Diagnostic Lab/Associate Professor of Pathology and Medicine, HMS
Boston Children's Hospital
Boston, MA, United States
Ellen Foxman, MD, PhD. (she/her/hers)

Associate Professor
Yale School of Medicine
New Haven , CT, United States

Faculty(s)

Ephraim Tsalik, MD PhD (he/him/his)

Chief Scientific Officer, Infectious Disease
Danaher
Cary, NC, United States
Karen Carroll, MD (she/her/hers)

Professor, Director, Division Medical Microbiology
Johns Hopkins University Sch
Baltimore, MD, United States
Ellen Foxman, MD, PhD. (she/her/hers)

Associate Professor
Yale School of Medicine
New Haven , CT, United States

Disclosure(s):

Nira R. Pollock, MD, PhD: No financial relationships to disclose

Ellen F. Foxman, MD, PhD.: No financial relationships to disclose

Ephraim L. Tsalik, MD PhD: Danaher: Employment (Ongoing), Stocks/Bonds (Public Company) (Ongoing), Systems and methods for artificial intelligence based infection classification using cell parameters or populations (Ongoing)

Karen C. Carroll, MD: BD Diagnostics, Inc: Advisor/Consultant (Ongoing); Co-Diagnostics, Inc.: Board Member (Ongoing); Cytovale Inc: Advisor/Consultant (Ongoing); Meridian Bioscience Inc.: Grant/Research Support (Ongoing); Pattern Diagnostics, Inc.: Advisor/Consultant (Terminated); Qiagen, Inc.: Grant/Research Support (Ongoing); Scanogen, Inc: Grant/Research Support (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

investigate host biomarkers currently in clinical use for infectious diseases diagnosis, including distinction of infection versus inflammation and bacterial versus viral infection;
Identify about host biomarkers currently being actively explored for potential infectious diseases diagnostic utility;
describe current research utilizing host biomarkers to drive pathogen discovery.

Presentations:

1:45 PM – 2:10 PM US PT

Host biomarkers for infectious diseases diagnosis: What’s current and what’s coming
Speaker: Ephraim L. Tsalik, MD PhD (he/him/his) – Danaher
2:10 PM – 2:35 PM US PT

Host biomarker tests for distinction of bacterial versus viral infection: overview and clinical case study
Speaker: Karen C. Carroll, MD (she/her/hers) – Johns Hopkins University Sch
2:35 PM – 3:00 PM US PT

Using host biomarkers to drive pathogen discovery
Speaker: Ellen F. Foxman, MD, PhD. (she/her/hers) – Yale School of Medicine